In rats, in vivo injection of GAD65 antibodies from patients with stiff-person syndrome (SPS) induced electrophysiologic changes in myelinated neurons, whereas GAD65 antibodies from patients with DM1 did not [133]. The gene discussed is GAD2; the disease is stiff-person syndrome.